Form 4: Health In Tech CISO Granted 8,000 Restricted Shares

Health In Tech, Inc.'s CISO, Michael David Clarkson, was granted 8,000 restricted shares of Class A Common Stock as part of the company's Equity Incentive Plan.

Summary

• Michael David Clarkson, the Chief Information Security Officer (CISO) of Health In Tech, Inc. (HIT), acquired 8,000 shares of Class A Common Stock.
• The transaction occurred on November 5, 2025, with the shares granted at a price of $0.00 per share.
• These shares are restricted and were granted under the Health in Tech Equity Incentive Plan.
• The restricted shares will vest in equal monthly installments over a twelve (12) month period, commencing on November 1, 2025.
• Vesting is contingent upon Mr. Clarkson's continued service with Health In Tech, Inc. through each applicable vesting date.
• Following this reported transaction, Mr. Clarkson directly beneficially owns 8,000 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted shares to a key executive is generally positive as it aligns management's interests with shareholders and incentivizes long-term performance, though it's a routine compensation event rather than a significant operational announcement.

Positives

• The grant of restricted shares aligns the CISO's long-term financial interests with those of the shareholders, incentivizing sustained performance.
• Participation in the equity incentive plan is a standard method for retaining and motivating key executive talent within the company.

Negatives

• The shares are restricted and vest over time, meaning the CISO does not have immediate liquidity or full ownership until the vesting conditions are met.

Risks

• The vesting of the restricted shares is subject to the reporting person's continued service with the issuer, meaning the shares could be forfeited if employment ceases before full vesting.

Future Outlook

The vesting schedule for the restricted shares indicates a strategic commitment to retaining key executives over the next twelve months, thereby aligning their incentives with the company's long-term performance and stability.

Industry Context

Equity grants to key executives, such as CISOs, are a standard and widespread practice across the technology and healthcare sectors. This compensation strategy is crucial for attracting, retaining, and motivating top talent, ensuring their performance is directly linked to the creation of shareholder value and the achievement of corporate objectives.

Comparison to Industry Standards

• Granting restricted stock to C-suite executives is a common compensation strategy across the tech and healthcare industries, similar to practices at companies like Google, Apple, and various biotech firms, to foster long-term commitment and performance.
• A 12-month vesting period, while potentially shorter than some multi-year grants, is not uncommon for certain types of incentive awards or for executives who may have other long-term equity components.

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive interests with shareholder value through equity ownership, fostering long-term commitment.
• Employees (specifically CISO): Direct impact on compensation structure and long-term incentives, enhancing retention and motivation.

Next Steps

• The 8,000 restricted shares will continue to vest in equal monthly installments over the next twelve months, commencing November 1, 2025, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine grant of restricted stock to a key executive as part of an established equity incentive plan. While positive for aligning management incentives with shareholder interests, it does not present new information that would fundamentally alter the company's valuation or operational outlook to warrant a change in investment recommendation. It is an expected part of executive compensation.

Keywords

Health In Tech, HIT, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, CISO, Michael Clarkson, Stock Grant, Executive Compensation